Phase I trial of INSYS Therapeutics' cannabidiol in adults

Trial Profile

Phase I trial of INSYS Therapeutics' cannabidiol in adults

Planning
Phase of Trial: Phase I

Latest Information Update: 11 Nov 2014

At a glance

  • Drugs Cannabidiol (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions; First in man
  • Sponsors INSYS Pharma
  • Most Recent Events

    • 11 Nov 2014 This phase I dose-ranging study will be conducted prior to phase III trials in Lennox-Gastaut and Dravet Syndrome, planned for 2015, according to an Insys Therapeutics media release.
    • 15 Oct 2014 The first human subject is expected to be dosed with cannabidiol in the first quarter of 2015, according to an Insys Therapeutics media release.
    • 12 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top